AREV NanoTec Brands Inc. announced the addition of Kevin J. Phelps to its Board of Directors. Mr. Phelps has a long history in the biotechnology and drug discovery industries, currently serving as the CEO of Immune Therapeutics Inc., and as Chairman of OyaGen Inc. Mr. Phelps began his career as a CPA with Price Waterhouse Coopers and the executive management team of Eastman Kodak Company and its affiliate, Genencor International Inc., which Mr. Phelps served as CFO and EVP of Business Development. He has also served as CFO of Vaccinex Inc. Mr. Phelps went on to join Trillium Group, LLC.